RespireRx Pharmaceuticals Inc. (RSPI)

RespireRx Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	0	0	1	1	0	2
Market Cap Growth	-70.60%	-75.23%	37.86%	91.84%	-82.06%	-20.99%
Enterprise Value	3	3	3	2	2	3
PE Ratio	-	-0.13	-0.27	-0.15	-0.16	-0.84
PB Ratio	-0.02	-0.02	-0.10	-0.09	-0.05	-0.38
P/FCF Ratio	-1.19	-1.78	-1.08	-1.46	-0.80	-5.10
P/OCF Ratio	-1.19	-1.78	-1.08	-1.46	-0.80	-5.10
EV/EBITDA Ratio	-1.69	-1.80	-1.22	-0.73	-1.16	-1.56
EV/EBIT Ratio	0.00	0.00	0.00	0.00	0.00	0.00
EV/FCF Ratio	-10.11	-20.60	-3.25	-4.74	-4.12	-7.94
Debt / Equity Ratio	-0.18	-0.23	-0.21	-0.21	-0.22	-0.22
Debt / EBITDA Ratio	-1.50	-1.64	-0.81	-0.51	-0.94	-0.57
Debt / FCF Ratio	-8.94	-18.82	-2.17	-3.28	-3.35	-2.92
Quick Ratio	0.00	0.00	0.00	0.00	0.00	0.01
Current Ratio	0.01	0.00	0.02	0.01	0.01	0.02
Interest Coverage	4.53	-2.62	-3.53	-6.08	-4.29	-15.98
Return on Equity (ROE)	15.81%	17.02%	38.67%	60.11%	33.84%	45.21%
Return on Assets (ROA)	-1789.35%	-8876.99%	-1853.82%	-5696.39%	-5558.80%	-2086.96%
Return on Capital (ROIC)	13.98%	17.22%	32.27%	51.96%	29.89%	48.55%
Earnings Yield	-532.10%	-789.82%	-374.36%	-646.41%	-644.68%	-118.99%
FCF Yield	-67.75%	-56.20%	-92.50%	-68.42%	-124.79%	-19.62%
Buyback Yield / Dilution	-124.49%	-26.01%	-241.69%	-6515.29%	-16.63%	-38.57%
Total Shareholder Return	-124.49%	-26.01%	-241.69%	-6515.29%	-16.63%	-38.57%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.